Where Global Biopharma Moves Forward

You’re expected to move faster while reducing cost and risk. But at enterprise scale, disconnected workflows and legacy systems make that harder than it should be.

Medidata helps 95% of the top 20 pharmaceutical companies modernize clinical development end-to-end—driving efficiency, improving visibility, and accelerating timelines across programs and regions.

View Success Stories
countries
0 +
patients
0 M+
sites
0 K+
of the top 20 pharmaceutical companies use Medidata technology
0 %
of FDA novel approvals used Medidata in 2025
0 %

Navigate Global Complexity with Expertise

You need a partner who understands the realities of device and diagnostic development—across therapeutic areas, regulatory pathways, and evolving evidence requirements.

Theraputic Depth
Unified 
Cloud-based Solution
Medidata Consult Program for Flexible Resourcing
End‑to‑end Support

Why Medidata

Proven Technology

Turn Innovation into Measurable Impact

Investing in new technologies and data only matters if it accelerates decisions and improves outcomes.

Bring digital capabilities, diverse data sources, and advanced analytics together in one connected environment to move from insight to action faster.

Contact an Expert

Featured Resource


The State of AI in Clinical Trials: Today and Tomorrow

A grounded look at how AI is being applied in regulated clinical research today, and what it takes to scale AI responsibly across development programs.

Download Report

More Resources


Explore deeper guidance and related materials.

View All Resources